This work aims to improve the practical utility of DCE derived quantitative biomarkers by comparing the repeatability of DCE calculated parameters across analysis methods, and across AIF choices. The data consists of two scans each from a set of 15 patients with suspected prostate cancer, repeated within 14 days without intervening therapy.
This abstract and the presentation materials are available to members only; a login is required.